drugset / Trial / NCT00887029

A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma

NCT00887029

RandomizedCrossoverSingle-blindTreatment

Summary

Hypothesis: * H1: Efficacy of Duotrav will be superior to Xalacom at 24 hours post dosing when both medications are given in the morning * H2: A significant proportion of patients will prefer dosing of once daily topical fixed combination therapy in the morning compared to evening dosing

Timeline

Start
2009-01
Primary completion
2009-11
Completion
2009-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule Topical
Comparator Travoprost Other / unclassified Topical
Comparator Timolol Other / unclassified Topical